Cystic fibrosis, vasoactive intestinal polypeptide, and active cutaneous vasodilation.
Cystic fibrosis, vasoactive intestinal polypeptide, and active cutaneous vasodilation.
复制标题
囊性纤维化、血管活性肠多肽和活性皮肤血管舒张。
DOI:
10.1152/jappl.1990.69.6.2149
复制
发表时间:
1990
期刊:
影响因子:
--
通讯作者:
Freund,PR
中科院分区:
文献类型:
--
作者:
Savage,MV;Brengelmann,GL;Buchan,AM;Freund,PR
The transmitter substance for the active cutaneous vasodilation that accompanies sweating during hyperthermia in humans is unknown. Hokfelt et al. (Nature Lond. 284: 515-521, 180) hypothesized that it is vasoactive intestinal polypeptide (VIP) that is cotransmitted with acetylcholine. Heinz-Erian et al. (Science Wash. DC 229: 1407-1408, 1985) reported that VIP innervation is sparse in the skin of persons with cystic fibrosis (CF). A corresponding attenuation of active vasodilation in these subjects would be evidence that VIP is involved in this effector mechanism of human thermor-regulation. Immunocytochemical analysis of skin biopsies from four men with CF confirmed that VIP innervation was sparse. We also analyzed immunoreactivity for calcitonin gene-related peptide (CGRP; normal), substance P (normal), and neuropeptide Y (low). VIP-immunoreactive Merkel cells were abnormal. Despite sparse VIP-immunoreactive innervation, our CF subjects' cutaneous vascular responses to hyperthermia were normal. Because VIP was not completely absent, this evidence is insufficient to rule out VIP as the vasodilator transmitter. However, the CGRP and substance P innervation we observed could mean that release of one or both of these peptides was the mechanism of the fully developed active cutaneous vasodilation.